FindTrial
Sign In

Clinical observation of laser peripheral iris angioplasty for acute angle-closure glaucoma

Clinical observation of laser peripheral iris angioplasty for acute angle-closure glaucoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027821
Enrollment
Unknown
Registered
2019-11-30
Start date
2019-11-27
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Three Groups:Different laser treatment points

Sponsors

Tianjin First Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Ages greater than 18 years, regardless of gender and race; 2. Acute angle-closure glaucoma; 3. Combination of 3 or more anti-glaucoma drugs, patients with uncontrollable intraocular pressure (=40mmHg); 4. Patients and their families have signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclude neovascular glaucoma, open-angle glaucoma, and congenital glaucoma; 2. Those who have undergone other internal eye surgery that may affect the evaluation of postoperative efficacy before enrollment; 3. Patients with more severe cardiovascular and cerebrovascular diseases, and major organ dysfunction; 4. with history of laser peripheral iris angioplasty or punching; 5. Patients cannot be followed up.

Design outcomes

Primary

MeasureTime frame
Anterior chamber angle Openness;—

Countries

China

Contacts

Public ContactLiu Zengye

Tianjin First Central Hospital

lzydoc@163.com+86 13820776407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026